Results 31 to 40 of about 1,405,405 (194)
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies [PDF]
Objectives: The paediatric idiopathic inflammatory myopathies (IIMs) are a group of rare chronic inflammatory disorders of childhood, affecting muscle, skin and other organs.
Juvenile Dermatomyositis Research Group +15 more
core +1 more source
Systemic juvenile idiopathic arthritis complicated by hemophagocytic syndrome
Systemic juvenile idiopathic arthritis is a polygenic autoinflammatory disease. Pronounced systemic clinical manifestations, a significant increase in the level of inflammatory markers and the absence of autoantibodies distinguish this disease from other
Natalya A. Belykh +4 more
doaj +1 more source
For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed ...
Scott W. Canna +12 more
doaj +1 more source
Macrophage activation syndrome, a severe complication of systemic juvenile idiopathic arthritis and other inflammatory diseases, represents one of the most important rheumatological emergencies.
Kenan Barut +4 more
doaj +1 more source
Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis
The article presents a case of using genetically engineered biopharmaceutical tocilizumab in a child with systemic juvenile idiopathic arthritis. On the initial stage, the treatment was characterized by resistance to high doses of glucocorticoids and ...
Y. M. Spivakovskiy +4 more
doaj +1 more source
Outcomes of Tocilizumab on the Disease Activity in Children with Juvenile Idiopathic Arthritis [PDF]
Background: Juvenile idiopathic arthritis (JIA) comprises a spectrum of chronic inflammatory joint disorders characterized by joint pain, swelling, stiffness, and restricted mobility in affected children. The interleukin-6 (IL-6) inhibitors, tocilizumab (
Rabab Elbehedy +5 more
doaj +1 more source
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert +43 more
wiley +1 more source
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi +10 more
wiley +1 more source
A rare de novo IFT122‐A773E variant is identified in idiopathic pediatric uveitis and shown to exacerbate retinal inflammation and barrier dysfunction. Mechanistically, the variant enhances IFT43 interaction, elevates calcium signaling, and activates the MEK/ERK/FRA1 axis, revealing a previously unrecognized cilia‐associated pathway that may increase ...
Qian Zhou +18 more
wiley +1 more source
Imaging of juvenile idiopathic arthritis. Part I: Clinical classifications and radiographs [PDF]
Juvenile idiopathic arthritis is the most common autoimmune systemic disease of the connective tissue affecting individuals at the developmental age. Radiography is the primary modality employed in the diagnostic imaging in order to identify changes ...
Iwona Sudoł-Szopińska +4 more
doaj +1 more source

